NMOSD—Diagnostic Dilemmas Leading towards Final Diagnosis

NMOSD—Diagnostic Dilemmas Leading towards Final Diagnosis

(1) Background: The emergence of white matter lesions in the central nervous system (CNS) can lead to diagnostic dilemmas. They are a common radiological symptom and their patterns may overlap CNS or systemic diseases and provoke underdiagnosis or misdiagnosis. The aim of the study was to assess fac...

Full description

Bibliographic Details
Main Authors:	Anna K. Szewczyk, Ewa Papuć, Krystyna Mitosek-Szewczyk, Michał Woś, Konrad Rejdak
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Series:	Brain Sciences
Subjects:	NMOSD neuromyelitis optica underdiagnosis misdiagnosis AQP4 antibody multiple sclerosis
Online Access:	https://www.mdpi.com/2076-3425/12/7/885

Similar Items

Sera from Patients with NMOSD Reduce the Differentiation Capacity of Precursor Cells in the Central Nervous System
by: Ulises Gómez-Pinedo, et al.
Published: (2021-05-01)

Neuromyelitis Optica Spectrum Disorders (NMOSD); Diagnostic criteria (ORP-56)
by: Maryam Poursadeghfard
Published: (2023-01-01)

Chronic Cognitive Impairment in AQP4+ NMOSD With Improvement in Cognition on Eculizumab: A Report of Two Cases
by: Georges Saab, et al.
Published: (2022-05-01)

Double seropositive neuromyelitis optica associated with COVID-19: A case report
by: Dana Antonescu Ghelmez, et al.
Published: (2022-10-01)

Different clinical phenotypes of AQP4-IgG positive NMOSD in two first degree relatives
by: Salvatore Ssemmanda, et al.
Published: (2023-09-01)

AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of Literature
by: Antonio Luca Spiezia, et al.
Published: (2022-11-01)

Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
by: Jyh Yung Hor, et al.
Published: (2020-06-01)

AQP4‐IgG positive paraneoplastic NMOSD: A case report and review
by: Manqiu Ding, et al.
Published: (2021-10-01)

The First Case Report of Preschool-Onset SS/SLE Coexisting With NMOSD of Chinese Origin
by: Liqun Liu, et al.
Published: (2022-05-01)

Peripheral memory B cells in multiple sclerosis vs. double negative B cells in neuromyelitis optica spectrum disorder: disease driving B cell subsets during CNS inflammation
by: M. P. Tieck, et al.
Published: (2024-02-01)

Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD
by: Judith Derdelinckx, et al.
Published: (2021-07-01)

Epidemiology of Pediatric NMOSD in Germany and Austria
by: Christian Lechner, et al.
Published: (2020-05-01)

The patient journey with NMOSD: From initial diagnosis to chronic condition
by: Guillermo Delgado-Garcia, et al.
Published: (2022-09-01)

A comparative analysis of clinical and imaging features of Aquaporin 4 (AQP4) antibody positive, Myelin Oligodendrocyte Glycoprotein (MOG) antibody positive and double seronegative subtypes of Neuro Myelitis Optica Spectrum Disorder (NMOSD)
by: Salil Gupta, et al.
Published: (2022-01-01)

Late-Onset Neuromyelitis Optica Spectrum Disorder Mimicking a Non-Arteritic Anterior Ischemic Optic Neuropathy–Case Report
by: Lech Sedlak, et al.
Published: (2023-06-01)

MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis
by: Laura Clarke, et al.
Published: (2021-09-01)

Correlations among disability, anti-AQP4 antibody status and prognosis in the spinal cord involved patients with NMOSD
by: Jung Lung Hsu, et al.
Published: (2021-04-01)

Impaired response of blood neutrophils to cell-death stimulus differentiates AQP4-IgG-seropositive NMOSD from MOGAD
by: Maria Schroeder-Castagno, et al.
Published: (2022-10-01)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
by: Elia Sechi, et al.
Published: (2022-06-01)

Aquaporin-4 IgG antibodies: predictors of positivity and their relationship with neuropsychiatric disorders and white matter lesions in Juvenile systemic lupus erythematosus
by: Yasmeen Shaaban, et al.
Published: (2023-05-01)

The history of neuromyelitis optica. Part 2: ‘Spinal amaurosis’, or how it all began
by: S. Jarius, et al.
Published: (2019-12-01)

Neuromyelitis optica spectrum disorder (NMOSD) – diagnosis, epidemiology, clinical course, treatment
by: Agnieszka Damiza-Detmer, et al.
Published: (2019-05-01)

Immunosuppressive therapy and COVID‐19 infection in patients with NMOSD
by: Un Wai Choi, et al.
Published: (2024-01-01)

Emerging trends and research foci of neuromyelitis optica spectrum disorder: a 20-year bibliometric analysis
by: Yue Su, et al.
Published: (2023-06-01)

Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation
by: Elham Khalilidehkordi, et al.
Published: (2020-06-01)

Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody‐associated disease
by: Joseph A Lopez, et al.
Published: (2021-01-01)

Anti-B-cell therapy in patients with neuromyelitis optica spectrum disorders
by: S. V. Kotov, et al.
Published: (2021-08-01)

NEUROMYELITIS OPTICA SPECTRUM DISORDERS: DIAGNOSIS AND TREATMENT, THE EXPERIENCE OF CLINICAL OBSERVATIONS
by: V. D. Piven, et al.
Published: (2018-12-01)

Comparison of clinical and radiological features of Aquaporin4 (AQP-4) antibody positive Neuromyelitis Optica Spectrum Disorder (NMOSD) and Anti Myelin Oligodendrocyte Glycoprotein (Anti-MOG) syndrome-our experience from Northwest India
by: Rajendra Singh Jain, et al.
Published: (2022-01-01)

Editorial: Real-world study of multiple sclerosis and related diseases in developing countries
by: Jinming Han, et al.
Published: (2023-11-01)

No association of AQP4 polymorphisms with neuromyelitis optica and multiple sclerosis
by: Yang Ting-Ting, et al.
Published: (2016-01-01)

Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies
by: Edgar Carnero Contentti, et al.
Published: (2021-09-01)

Aquaporin-4 in Neuromyelitis Optica Spectrum Disorders: A Target of Autoimmunity in the Central Nervous System
by: Yoichiro Abe, et al.
Published: (2022-04-01)

Is There a Need to Differentiate Atypical Multiple Sclerosis from Neuromyelitis Optica Spectrum Disorders (NMOSD)? The Pros and Cons: A Systematic Review (PP-21)
by: Sepideh Paybast, et al.
Published: (2023-01-01)

Drug Treatment of Neuromyelitis Optica Spectrum Disorders: Out with the Old, in with the New?
by: Held F, et al.
Published: (2021-03-01)

A retrospective study of myelin oligodendrocyte glycoprotein antibody-associated disease from a clinical laboratory perspective
by: Yufei Wang, et al.
Published: (2023-09-01)

The risk factors of neuropathic pain in neuromyelitis optica spectrum disorder: a retrospective case-cohort study
by: Xiaojun Li, et al.
Published: (2022-08-01)

Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations
by: Han J, et al.
Published: (2017-10-01)

Adverse Events in NMOSD Therapy
by: Katrin Giglhuber, et al.
Published: (2022-04-01)

Hypersensitivity responses in the central nervous system
by: Reza eKhorooshi, et al.
Published: (2015-10-01)